Delivery Order SPE2DB20D3103-SPE2DB25FN7G8

Award Date 5/7/25
Potential Completion Date 5/29/25
Potential Value $9.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,910.95, is for the supply of the prescription medication Lenvima 10 mg with a performance period through May 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lenvima 18 mg daily dose medication. The contract has a ceiling value of $9,910.95 and a performance period extending through April 29, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Lenvima 14 mg daily dose 60s. The contract has a ceiling value of $9,910.95 and a period of performance through April 30, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $18,559.58. The contract is for the supply of the pharmaceutical product Lenvima 14 mg daily dose, with a completion date of June 5, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,910.95, is for the delivery of LENVIMA 24 MG DAILY DOSE 90S, a pharmaceutical product. The contract has a period of performance through February 4, 2025 and is a firm fixed-price type. No set-aside designation was used. Amerisourcebergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,910.95, is for the delivery of the medication Lenvima 14 mg daily dose, a treatment for certain types of cancer. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,910.95, is for the supply of LENVIMA 10 MG DAILY DOSE 30S, a pharmaceutical product. The contract is a Firm Fixed Price (FFP) Delivery Order, with an ultimate completion date of April 11, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $9,279.78 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the provision of LENVIMA 14 MG DAILY DOSE 60S. The contract has a completion date of March 4, 2024 and was awarded on February 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 with a performance...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of the pharmaceutical product LENVIMA 14 MG DAILY DOSE 60S, with a completion date of March 12, 2024 and a potential value of $9,279.78. Amerisourcebergen Drug Corp is the prime contractor and there are no known major subcontractors. This delivery order is part of a larger indefinite...
This is a $37,119.16 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of LENVIMA 8 MG DAILY DOSE 60S, a specialty medication, to support federal healthcare programs. It has an ultimate completion date of January 24, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN7G8
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription medication Lenvima 8 mg, with a ceiling value of $9,910.95 and a period of performance through May 29, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is part of the company's broader portfolio of federal contracts to supply a wide range of pharmaceutical products and medical supplies to support military and government healthcare programs.

Generated 8/6/25, 9:58 AM